ID   GSTM2_HUMAN             Reviewed;         218 AA.
AC   P28161; B4DRY4; E9PEM9; Q2M318; Q5TZY5; Q8WWE1;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   10-MAY-2017, entry version 177.
DE   RecName: Full=Glutathione S-transferase Mu 2;
DE            EC=2.5.1.18;
DE   AltName: Full=GST class-mu 2;
DE   AltName: Full=GSTM2-2;
GN   Name=GSTM2; Synonyms=GST4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RX   PubMed=2034681; DOI=10.1073/pnas.88.10.4443;
RA   Vorachek W.R., Pearson W.R., Rule G.S.;
RT   "Cloning, expression, and characterization of a class-mu glutathione
RT   transferase from human muscle, the product of the GST4 locus.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:4443-4447(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF N-TERMINUS.
RC   TISSUE=Testis;
RX   PubMed=8373352; DOI=10.1042/bj2940373;
RA   Ross V.L., Board P.G.;
RT   "Molecular cloning and heterologous expression of an alternatively
RT   spliced human Mu class glutathione S-transferase transcript.";
RL   Biochem. J. 294:373-380(1993).
RN   [7]
RP   PROTEIN SEQUENCE OF 53-69 AND 153-182, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Vishwanath V.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) IN COMPLEX WITH GLUTATHIONE,
RP   AND SUBUNIT.
RX   PubMed=8182750; DOI=10.1006/jmbi.1994.1336;
RA   Raghunathan S., Chandross R.J., Kretsinger R.H., Allison T.J.,
RA   Penington C.J., Rule G.S.;
RT   "Crystal structure of human class mu glutathione transferase GSTM2-2.
RT   Effects of lattice packing on conformational heterogeneity.";
RL   J. Mol. Biol. 238:815-832(1994).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.35 ANGSTROMS) IN COMPLEX WITH GLUTATHIONE
RP   ANALOG, FUNCTION, MUTAGENESIS OF THR-210, AND CATALYTIC ACTIVITY.
RX   PubMed=16549767; DOI=10.1073/pnas.0600849103;
RA   Norrgard M.A., Ivarsson Y., Tars K., Mannervik B.;
RT   "Alternative mutations of a positively selected residue elicit gain or
RT   loss of functionalities in enzyme evolution.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:4876-4881(2006).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEX WITH GLUTATHIONE AND
RP   NBDHEX.
RX   PubMed=19808963; DOI=10.1158/0008-5472.CAN-09-1314;
RA   Federici L., Lo Sterzo C., Pezzola S., Di Matteo A., Scaloni F.,
RA   Federici G., Caccuri A.M.;
RT   "Structural basis for the binding of the anticancer compound 6-(7-
RT   nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol to human glutathione s-
RT   transferases.";
RL   Cancer Res. 69:8025-8034(2009).
CC   -!- FUNCTION: Conjugation of reduced glutathione to a wide number of
CC       exogenous and endogenous hydrophobic electrophiles.
CC       {ECO:0000269|PubMed:16549767}.
CC   -!- CATALYTIC ACTIVITY: RX + glutathione = HX + R-S-glutathione.
CC       {ECO:0000269|PubMed:16549767}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:16549767,
CC       ECO:0000269|PubMed:19808963, ECO:0000269|PubMed:8182750}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P28161-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P28161-2; Sequence=VSP_045614;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Muscle.
CC   -!- SIMILARITY: Belongs to the GST superfamily. Mu family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M63509; AAA60963.1; -; mRNA.
DR   EMBL; AK299482; BAG61446.1; -; mRNA.
DR   EMBL; BT019947; AAV38750.1; -; mRNA.
DR   EMBL; AC000031; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC000032; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC105038; AAI05039.1; -; mRNA.
DR   EMBL; BC105066; AAI05067.1; -; mRNA.
DR   CCDS; CCDS44192.1; -. [P28161-2]
DR   CCDS; CCDS808.1; -. [P28161-1]
DR   PIR; A39375; A39375.
DR   RefSeq; NP_000839.1; NM_000848.3. [P28161-1]
DR   RefSeq; NP_001135840.1; NM_001142368.1. [P28161-2]
DR   UniGene; Hs.279837; -.
DR   PDB; 1HNA; X-ray; 1.85 A; A=2-218.
DR   PDB; 1HNB; X-ray; 3.50 A; A/B=2-218.
DR   PDB; 1HNC; X-ray; 3.00 A; A/B/C/D=2-218.
DR   PDB; 1XW5; X-ray; 1.80 A; A/B=2-218.
DR   PDB; 1YKC; X-ray; 2.10 A; A/B=2-218.
DR   PDB; 2AB6; X-ray; 2.50 A; A/B/C/D=2-218.
DR   PDB; 2C4J; X-ray; 1.35 A; A/B/C/D=2-218.
DR   PDB; 2GTU; X-ray; 2.55 A; A/B=2-218.
DR   PDB; 3GTU; X-ray; 2.80 A; A/C=2-218.
DR   PDB; 3GUR; X-ray; 2.50 A; A/B/C/D=2-218.
DR   PDBsum; 1HNA; -.
DR   PDBsum; 1HNB; -.
DR   PDBsum; 1HNC; -.
DR   PDBsum; 1XW5; -.
DR   PDBsum; 1YKC; -.
DR   PDBsum; 2AB6; -.
DR   PDBsum; 2C4J; -.
DR   PDBsum; 2GTU; -.
DR   PDBsum; 3GTU; -.
DR   PDBsum; 3GUR; -.
DR   ProteinModelPortal; P28161; -.
DR   SMR; P28161; -.
DR   BioGrid; 109201; 6.
DR   IntAct; P28161; 2.
DR   STRING; 9606.ENSP00000241337; -.
DR   BindingDB; P28161; -.
DR   ChEMBL; CHEMBL4589; -.
DR   DrugBank; DB00143; Glutathione.
DR   DrugBank; DB03310; Oxidized Glutathione Disulfide.
DR   DrugBank; DB04701; S-METHYL-GLUTATHIONE.
DR   SwissLipids; SLP:000001614; -.
DR   iPTMnet; P28161; -.
DR   PhosphoSitePlus; P28161; -.
DR   BioMuta; GSTM2; -.
DR   DMDM; 232204; -.
DR   OGP; P28161; -.
DR   REPRODUCTION-2DPAGE; P28161; -.
DR   EPD; P28161; -.
DR   MaxQB; P28161; -.
DR   PaxDb; P28161; -.
DR   PeptideAtlas; P28161; -.
DR   PRIDE; P28161; -.
DR   DNASU; 2946; -.
DR   Ensembl; ENST00000241337; ENSP00000241337; ENSG00000213366. [P28161-1]
DR   Ensembl; ENST00000442650; ENSP00000416883; ENSG00000213366. [P28161-2]
DR   Ensembl; ENST00000460717; ENSP00000435910; ENSG00000213366. [P28161-2]
DR   GeneID; 2946; -.
DR   KEGG; hsa:2946; -.
DR   UCSC; uc001dyj.4; human. [P28161-1]
DR   CTD; 2946; -.
DR   DisGeNET; 2946; -.
DR   GeneCards; GSTM2; -.
DR   HGNC; HGNC:4634; GSTM2.
DR   HPA; CAB040547; -.
DR   HPA; HPA055972; -.
DR   HPA; HPA055973; -.
DR   MIM; 138380; gene.
DR   neXtProt; NX_P28161; -.
DR   OpenTargets; ENSG00000213366; -.
DR   PharmGKB; PA29023; -.
DR   eggNOG; ENOG410IN5J; Eukaryota.
DR   eggNOG; ENOG4110YU0; LUCA.
DR   GeneTree; ENSGT00550000074559; -.
DR   HOGENOM; HOG000115735; -.
DR   HOVERGEN; HBG106842; -.
DR   InParanoid; P28161; -.
DR   KO; K00799; -.
DR   OMA; RITESWA; -.
DR   PhylomeDB; P28161; -.
DR   TreeFam; TF353040; -.
DR   BRENDA; 2.5.1.18; 2681.
DR   Reactome; R-HSA-156590; Glutathione conjugation.
DR   SABIO-RK; P28161; -.
DR   ChiTaRS; GSTM2; human.
DR   EvolutionaryTrace; P28161; -.
DR   GeneWiki; GSTM2; -.
DR   GenomeRNAi; 2946; -.
DR   PRO; PR:P28161; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000213366; -.
DR   CleanEx; HS_GSTM2; -.
DR   ExpressionAtlas; P28161; baseline and differential.
DR   Genevisible; P28161; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; IDA:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0043295; F:glutathione binding; IDA:BHF-UCL.
DR   GO; GO:0004602; F:glutathione peroxidase activity; IDA:BHF-UCL.
DR   GO; GO:0004364; F:glutathione transferase activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0005102; F:receptor binding; IPI:BHF-UCL.
DR   GO; GO:0070458; P:cellular detoxification of nitrogen compound; IDA:BHF-UCL.
DR   GO; GO:0071313; P:cellular response to caffeine; IDA:BHF-UCL.
DR   GO; GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome.
DR   GO; GO:0006749; P:glutathione metabolic process; IDA:UniProtKB.
DR   GO; GO:0043651; P:linoleic acid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0060315; P:negative regulation of ryanodine-sensitive calcium-release channel activity; IDA:BHF-UCL.
DR   GO; GO:0018916; P:nitrobenzene metabolic process; IDA:BHF-UCL.
DR   GO; GO:0060316; P:positive regulation of ryanodine-sensitive calcium-release channel activity; IDA:BHF-UCL.
DR   GO; GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; IC:BHF-UCL.
DR   GO; GO:0010880; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; IDA:BHF-UCL.
DR   GO; GO:0014809; P:regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; IC:BHF-UCL.
DR   GO; GO:0055119; P:relaxation of cardiac muscle; TAS:BHF-UCL.
DR   GO; GO:0042178; P:xenobiotic catabolic process; IDA:UniProtKB.
DR   InterPro; IPR010987; Glutathione-S-Trfase_C-like.
DR   InterPro; IPR004045; Glutathione_S-Trfase_N.
DR   InterPro; IPR004046; GST_C.
DR   InterPro; IPR003081; GST_mu.
DR   InterPro; IPR012336; Thioredoxin-like_fold.
DR   Pfam; PF00043; GST_C; 1.
DR   Pfam; PF02798; GST_N; 1.
DR   PRINTS; PR01267; GSTRNSFRASEM.
DR   SUPFAM; SSF47616; SSF47616; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   PROSITE; PS50405; GST_CTER; 1.
DR   PROSITE; PS50404; GST_NTER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P15626}.
FT   CHAIN         2    218       Glutathione S-transferase Mu 2.
FT                                /FTId=PRO_0000185818.
FT   DOMAIN        2     88       GST N-terminal.
FT   DOMAIN       90    208       GST C-terminal.
FT   REGION        7      8       Glutathione binding.
FT                                {ECO:0000269|PubMed:16549767,
FT                                ECO:0000269|PubMed:19808963}.
FT   REGION       43     46       Glutathione binding.
FT                                {ECO:0000269|PubMed:16549767,
FT                                ECO:0000269|PubMed:19808963}.
FT   REGION       59     60       Glutathione binding.
FT                                {ECO:0000269|PubMed:16549767,
FT                                ECO:0000269|PubMed:19808963}.
FT   REGION       72     73       Glutathione binding.
FT                                {ECO:0000269|PubMed:16549767,
FT                                ECO:0000269|PubMed:19808963}.
FT   BINDING      50     50       Glutathione.
FT                                {ECO:0000250|UniProtKB:P08010}.
FT   BINDING     116    116       Substrate. {ECO:0000250}.
FT   SITE        210    210       Important for substrate specificity.
FT   MOD_RES      27     27       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P08010}.
FT   MOD_RES      44     44       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P08010}.
FT   VAR_SEQ     190    218       GLEKISAYMKSSRFLPRPVFTKMAVWGNK -> HS (in
FT                                isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_045614.
FT   VARIANT     173    173       S -> N (in dbSNP:rs2229050).
FT                                /FTId=VAR_049486.
FT   MUTAGEN     210    210       T->C,F,H,I,K,L,R,Y,W: Reduced enzyme
FT                                activity. {ECO:0000269|PubMed:16549767}.
FT   CONFLICT      2      2       P -> S (in Ref. 3; AAV38750).
FT                                {ECO:0000305}.
FT   CONFLICT      9      9       N -> D (in Ref. 3; AAV38750).
FT                                {ECO:0000305}.
FT   CONFLICT     51     51       F -> L (in Ref. 2; BAG61446).
FT                                {ECO:0000305}.
FT   STRAND        3     11       {ECO:0000244|PDB:2C4J}.
FT   HELIX        12     14       {ECO:0000244|PDB:2C4J}.
FT   HELIX        15     23       {ECO:0000244|PDB:2C4J}.
FT   STRAND       28     33       {ECO:0000244|PDB:2C4J}.
FT   TURN         38     41       {ECO:0000244|PDB:2C4J}.
FT   HELIX        44     47       {ECO:0000244|PDB:2C4J}.
FT   TURN         48     51       {ECO:0000244|PDB:2C4J}.
FT   STRAND       60     65       {ECO:0000244|PDB:2C4J}.
FT   STRAND       68     72       {ECO:0000244|PDB:2C4J}.
FT   HELIX        73     83       {ECO:0000244|PDB:2C4J}.
FT   HELIX        91    116       {ECO:0000244|PDB:2C4J}.
FT   HELIX       120    142       {ECO:0000244|PDB:2C4J}.
FT   STRAND      150    152       {ECO:0000244|PDB:2C4J}.
FT   HELIX       155    170       {ECO:0000244|PDB:2C4J}.
FT   TURN        172    177       {ECO:0000244|PDB:2C4J}.
FT   HELIX       179    190       {ECO:0000244|PDB:2C4J}.
FT   HELIX       192    199       {ECO:0000244|PDB:2C4J}.
FT   STRAND      200    202       {ECO:0000244|PDB:1XW5}.
FT   STRAND      205    207       {ECO:0000244|PDB:1HNC}.
FT   TURN        208    212       {ECO:0000244|PDB:1HNA}.
FT   STRAND      214    216       {ECO:0000244|PDB:2C4J}.
SQ   SEQUENCE   218 AA;  25745 MW;  15203709D4A63789 CRC64;
     MPMTLGYWNI RGLAHSIRLL LEYTDSSYEE KKYTMGDAPD YDRSQWLNEK FKLGLDFPNL
     PYLIDGTHKI TQSNAILRYI ARKHNLCGES EKEQIREDIL ENQFMDSRMQ LAKLCYDPDF
     EKLKPEYLQA LPEMLKLYSQ FLGKQPWFLG DKITFVDFIA YDVLERNQVF EPSCLDAFPN
     LKDFISRFEG LEKISAYMKS SRFLPRPVFT KMAVWGNK
//
